Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Hepatocellular 7 Leukemia, Myeloid, Acute 5 Hepatitis C 5 Recurrence 4 Hepatitis C, Chronic 4 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Follicular 3 Respiratory Tract Infections 2 Lymphoma, Mantle-Cell 2 Infections 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Wilms Tumor 1 Testicular Neoplasms 1 Teratoma, Testicular 1 Teratoma 1 Seminoma 1 Respiratory Syncytial Virus Infections 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pneumonia 1 Neuroblastoma 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Malignant Solid Tumor 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Cyclophosphamide 346 Cytarabine 282 fludarabine phosphate 203 Methotrexate 186 Filgrastim 159 Busulfan 148 Etoposide 135 Peripheral Blood Stem Cell Transplantation 134 fludarabine 128 Rituximab 119 Radiotherapy 111 Vincristine 102 Cyclosporine 98 Daunorubicin 96 Antilymphocyte Serum 94 Dexamethasone 91 Tacrolimus 86 Mycophenolic Acid 86 Whole-Body Irradiation 81 Melphalan 79 Imatinib Mesylate 69 Idarubicin 67 Mercaptopurine 66 Granulocyte Colony-Stimulating Factor 66 Azacitidine 65 Methylprednisolone 59 Prednisone 58 Doxorubicin 58 Clofarabine 54 sargramostim 53

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia × Ribavirin × Clear all

NCT00559091 2022-12-22

Borden-001

Jewish General Hospital

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡